
Benjamin L. Lebron
Examiner (ID: 7336, Phone: (571)272-0475 , Office: P/1777 )
| Most Active Art Unit | 1777 |
| Art Unit(s) | 1777, 1773 |
| Total Applications | 617 |
| Issued Applications | 402 |
| Pending Applications | 48 |
| Abandoned Applications | 180 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17774857
[patent_doc_number] => 20220241206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/475622
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17475622
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/475622 | Pharmaceutical composition and administrations thereof | Sep 14, 2021 | Issued |
Array
(
[id] => 18724318
[patent_doc_number] => 20230338454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => FORSYTHIA SUSPENSA COMPONENT AND OPTIONAL PANAX GINSENG COMPONENT AND THE APPLICATION
[patent_app_type] => utility
[patent_app_number] => 18/024173
[patent_app_country] => US
[patent_app_date] => 2021-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024173
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024173 | FORSYTHIA SUSPENSA COMPONENT AND OPTIONAL PANAX GINSENG COMPONENT AND THE APPLICATION | Aug 30, 2021 | Abandoned |
Array
(
[id] => 18595871
[patent_doc_number] => 20230270660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => Silybum marianum (L.) Gaertn. oil for reinforcing the barrier function of the skin
[patent_app_type] => utility
[patent_app_number] => 18/042679
[patent_app_country] => US
[patent_app_date] => 2021-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042679
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042679 | Silybum marianum (L.) Gaertn. oil for reinforcing the barrier function of the skin | Aug 30, 2021 | Pending |
Array
(
[id] => 17290797
[patent_doc_number] => 20210386636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => Composition for Enhancing Hair Fiber Properties
[patent_app_type] => utility
[patent_app_number] => 17/410531
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410531 | Composition for enhancing hair fiber properties | Aug 23, 2021 | Issued |
Array
(
[id] => 18994672
[patent_doc_number] => 11911490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Aerosol device for hair shaping and/or hairstyle hold
[patent_app_type] => utility
[patent_app_number] => 17/397378
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 21
[patent_no_of_words] => 8487
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/397378 | Aerosol device for hair shaping and/or hairstyle hold | Aug 8, 2021 | Issued |
Array
(
[id] => 18595975
[patent_doc_number] => 20230270765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => APOTHECARIAL COMPOSITIONS AND RELATED METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/040022
[patent_app_country] => US
[patent_app_date] => 2021-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040022
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040022 | APOTHECARIAL COMPOSITIONS AND RELATED METHODS OF TREATMENT | Aug 1, 2021 | Abandoned |
Array
(
[id] => 18550638
[patent_doc_number] => 20230248638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => A PERSONAL CARE COMPOSITION COMPRISING ATRACTYLENOLIDE-I OR A SOURCE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/015545
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015545
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015545 | A PERSONAL CARE COMPOSITION COMPRISING ATRACTYLENOLIDE-I OR A SOURCE THEREOF | Jul 13, 2021 | Pending |
Array
(
[id] => 18536063
[patent_doc_number] => 20230241150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => Compositions and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/002669
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002669
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/002669 | Compositions and Uses Thereof | Jul 12, 2021 | Abandoned |
Array
(
[id] => 18581601
[patent_doc_number] => 20230263853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => ECTOPARASITICIDE VETERINARY COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/017133
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017133
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/017133 | ECTOPARASITICIDE VETERINARY COMPOSITION | Jun 30, 2021 | Abandoned |
Array
(
[id] => 18091332
[patent_doc_number] => 20220409673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => METHOD FOR TREATING NOCICEPTIVE PAIN AND BURNS WITH BRAZILIAN GREEN PROPOLIS ALCOHOL EXTRACT
[patent_app_type] => utility
[patent_app_number] => 17/362083
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17362083
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/362083 | Method for treating nociceptive pain and burns with brazilian green propolis alcohol extract | Jun 28, 2021 | Issued |
Array
(
[id] => 17168800
[patent_doc_number] => 20210322470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => CROSS-LINKING AGENTS AND ASSOCIATED METHODS
[patent_app_type] => utility
[patent_app_number] => 17/360610
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17360610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/360610 | CROSS-LINKING AGENTS AND ASSOCIATED METHODS | Jun 27, 2021 | Pending |
Array
(
[id] => 19246027
[patent_doc_number] => 20240197010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => AN ELASTOMERIC ARTICLE
[patent_app_type] => utility
[patent_app_number] => 18/286181
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286181
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/286181 | AN ELASTOMERIC ARTICLE | Jun 15, 2021 | Pending |
Array
(
[id] => 18647780
[patent_doc_number] => 20230293552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => HARD CAPSULE DOSAGE FORM AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/005946
[patent_app_country] => US
[patent_app_date] => 2021-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005946 | HARD CAPSULE DOSAGE FORM AND USES THEREOF | May 30, 2021 | Pending |
Array
(
[id] => 17258611
[patent_doc_number] => 20210371596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => Novel Antimicrobial Topical Skin Closure Compositions and Systems
[patent_app_type] => utility
[patent_app_number] => 17/327952
[patent_app_country] => US
[patent_app_date] => 2021-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327952
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327952 | Antimicrobial anhydrous topical skin closure compositions and systems | May 23, 2021 | Issued |
Array
(
[id] => 17183743
[patent_doc_number] => 20210330628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => Pharmaceutical Compositions Comprising Dimethyl Fumarate
[patent_app_type] => utility
[patent_app_number] => 17/316861
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316861
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/316861 | Pharmaceutical Compositions Comprising Dimethyl Fumarate | May 10, 2021 | Abandoned |
Array
(
[id] => 18404567
[patent_doc_number] => 20230165918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => REDUCTION OF CYTOKINE STORM AND PATHOLOGICAL INFLAMMATION INCLUDING CAUSED BY CORONAVIRUS USING SPHAGNUM AND EXTRACTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/997674
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997674 | REDUCTION OF CYTOKINE STORM AND PATHOLOGICAL INFLAMMATION INCLUDING CAUSED BY CORONAVIRUS USING SPHAGNUM AND EXTRACTS THEREOF | May 3, 2021 | Pending |
Array
(
[id] => 18433470
[patent_doc_number] => 20230180764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => THREE-DIMENSIONALLY PRINTABLE ANTIVIRAL FILAMENT
[patent_app_type] => utility
[patent_app_number] => 17/997414
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997414 | THREE-DIMENSIONALLY PRINTABLE ANTIVIRAL FILAMENT | Apr 25, 2021 | Pending |
Array
(
[id] => 17198627
[patent_doc_number] => 20210338721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => BIOAVAILABLE MINERALS FOR THE MITIGATION OF PATHOGENS IN ANIMALS, A MANUFACTURING METHOD AND A TREATMENT METHOD
[patent_app_type] => utility
[patent_app_number] => 17/237477
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237477
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/237477 | BIOAVAILABLE MINERALS FOR THE MITIGATION OF PATHOGENS IN ANIMALS, A MANUFACTURING METHOD AND A TREATMENT METHOD | Apr 21, 2021 | Abandoned |
Array
(
[id] => 18362595
[patent_doc_number] => 20230144186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/996853
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996853
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996853 | QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE | Apr 20, 2021 | Pending |
Array
(
[id] => 17799056
[patent_doc_number] => 11413323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Ophthalmic composition for treatment of dry eye disease
[patent_app_type] => utility
[patent_app_number] => 17/228309
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 22274
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228309
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228309 | Ophthalmic composition for treatment of dry eye disease | Apr 11, 2021 | Issued |